Guardant Health

YTD

ALL

Trade Guardant Health 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GH

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection.

CEO

Helmy Eltoukhy

CEOHelmy Eltoukhy

Employees

2,021

Employees2,021

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2011

Founded2011

Employees

2,021

Employees2,021

GH Key Statistics

Market cap

13.16B

Market cap13.16B

Price-Earnings ratio

-31.67

Price-Earnings ratio-31.67

Dividend yield

—

Dividend yield—

Average volume

1.50M

Average volume1.50M

High today

$102.92

High today$102.92

Low today

$100.80

Low today$100.80

Open price

$102.30

Open price$102.30

Volume

1.02M

Volume1.02M

52 Week high

$112.43

52 Week high$112.43

52 Week low

$31.72

52 Week low$31.72

Stock Snapshot

With a market cap of 13.16B, Guardant Health(GH) trades at $101.74. The stock has a price-to-earnings ratio of -31.67.

During the trading session on 2026-01-04, Guardant Health(GH) shares reached a daily high of $102.92 and a low of $100.80. At a current price of $101.74, the stock is +0.9% higher than the low and still -1.1% under the high.

Trading volume for Guardant Health(GH) stock has reached 1.02M, versus its average volume of 1.5M.

Over the past 52 weeks, Guardant Health(GH) stock has traded between a high of $112.43 and a low of $31.72.

Analyst ratings

88%

of 26 ratings

Buy

88.5%

Hold

7.7%

Sell

3.8%

People also own

Based on the portfolios of people who own GH. This list is generated using Robinhood data, and it’s not a recommendation.